About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Monthly Archives: April 2008
More Letters from the Hill – Looking at DTC
The flurry of paper trailing down Capitol Hill to various folks working in and regulating the pharmaceutical industry continues. Recently members of both the House and the Senate have sent letters to manufacturers of treatments that have lately been in … Continue reading
Posted in DTC Advertising
Comments Off on More Letters from the Hill – Looking at DTC
Heparin – Out of Adversity Comes Opportunity
The recent issues involving safety and the blood-thinner Heparin have dominated pharma news lately. While it is one more story about dangers with a drug product that were not anticipated, it stands out on its own. That is because it … Continue reading
Posted in Pharma Industry Image
5 Comments